The WACC of Nippon Chemiphar Co Ltd (4539.T) is 4.3%.
Range | Selected | |
Cost of equity | 6.3% - 9.3% | 7.8% |
Tax rate | 28.9% - 29.9% | 29.4% |
Cost of debt | 4.0% - 4.5% | 4.25% |
WACC | 3.8% - 4.9% | 4.3% |
Category | Low | High |
Long-term bond rate | 1.4% | 1.9% |
Equity market risk premium | 6.1% | 7.1% |
Adjusted beta | 0.79 | 0.97 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.3% | 9.3% |
Tax rate | 28.9% | 29.9% |
Debt/Equity ratio | 2.61 | 2.61 |
Cost of debt | 4.0% | 4.5% |
After-tax WACC | 3.8% | 4.9% |
Selected WACC | 4.3% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
4539.T | Nippon Chemiphar Co Ltd | 2.61 | 0.2 | 0.07 |
4512.T | Wakamoto Pharmaceutical Co Ltd | 0.01 | 0.38 | 0.38 |
4521.T | Kaken Pharmaceutical Co Ltd | 0.02 | 0.28 | 0.28 |
4530.T | Hisamitsu Pharmaceutical Co Inc | 0.01 | 0.2 | 0.2 |
4538.T | Fuso Pharmaceutical Industries Ltd | 0.58 | 0.78 | 0.55 |
4541.T | Nichi-Iko Pharmaceutical Co Ltd | 6.6 | 0.32 | 0.06 |
4548.T | Seikagaku Corp | 0.01 | 0.87 | 0.86 |
4554.T | Fuji Pharma Co Ltd | 0.9 | 0.88 | 0.54 |
4577.T | Daito Pharmaceutical Co Ltd | 0.27 | 0.36 | 0.3 |
4581.T | Taisho Pharmaceutical Holdings Co Ltd | 0 | -0.18 | -0.18 |
Low | High | |
Unlevered beta | 0.24 | 0.33 |
Relevered beta | 0.69 | 0.96 |
Adjusted relevered beta | 0.79 | 0.97 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 4539.T:
cost_of_equity (7.80%) = risk_free_rate (1.65%) + equity_risk_premium (6.60%) * adjusted_beta (0.79) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.